共 23 条
[1]
Urba W.J., Longo D.L., Hodgkin's disease, New Engl. J. Med., 32, 6, pp. 678-687, (1992)
[2]
Canellos P., Anderson J.R., Propert K.J., Et al., Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD, N ew Engl. J. Med, 327, pp. 1478-1484, (1992)
[3]
Gribben J.G., Vaughan Hudson B., Linch D.C., The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphoma, Haematol. Oncol., 52, pp. 81-293, (1987)
[4]
Bonnadonna G., Santoro A., Gianna A.M., Primary and salvage therapy in advanced Hodgkin's disease: The Milan Cancer Institute Experience, Ann. Oncol., 2, pp. 9-16, (1991)
[5]
Gribben J.G., Linch D.C., Singer C.R.J., McMillan A.K., Jarrett M., Goldstone A.H., Successful treatment of refractory Hodgkin's disease by high dose combination chemotherapy and autologous bone marrow transplantation, Blood, 1, pp. 340-344, (1989)
[6]
DeVita V.T., Hubbard S.M., Hodgkin's disease, New Engl. J. Med, 328, pp. 560-565, (1993)
[7]
Carella A.M., Carlier P., Congiu D., Et al., Autologous bone marrow transplantation as adjuvant treatment for high risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol, Bone Marrow Transplantation, 8, pp. 99-103, (1991)
[8]
Hancock B.W., Vaughan Hudson G., Vaughan Hudson B., Et al., LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease.: Results of a British National Lymphoma Investigation trial, J. Clin. Oncol., 10, pp. 1252-1258, (1992)
[9]
Crump M., Smith A.M., Brandwein J., Et al., High dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant, J. Clin. Oncol., 11, pp. 704-711, (1993)
[10]
Armitage J.O., Bierman P.J., Vose J.M., Et al., Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease, Am. J. Med, 91, pp. 605-611, (1991)